Common Contracts
4 similar Employment Agreement contracts by Proteon Therapeutics Inc
Proteon Therapeutics, Inc. Waltham, MA 02451 October 1, 2014Employment Agreement • October 7th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Reference is hereby made to that certain Employment Letter Agreement (the “Original Employment Agreement”), dated as of September 9, 2013, between you and Proteon Therapeutics, Inc. (the “Company” or “Proteon”). This letter agreement (the “Agreement”) amends and restates the Original Employment Agreement in its entirety. This letter contains the basic terms of your employment with the Company. If you agree to the terms and conditions set forth in this offer letter, please sign at the end of this letter in the space indicated. This Agreement shall be effective contingent upon, and from and after, the consummation of the Company’s initial public offering (the “IPO”) of its common stock, par value $0.001 per share (“Common Stock”).
Proteon Therapeutics, Inc. Waltham, MA 02451 October 1, 2014Employment Agreement • October 7th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Reference is hereby made to that certain employment letter agreement, dated as of July 19, 2007, between you and Proteon Therapeutics, Inc. (the “Company” or “Proteon”) and that certain severance agreement, dated as of September 23, 2013, between you and the Company (the “Original Employment Agreements”). This letter agreement (the “Agreement”) amends and restates the Original Employment Agreements, as amended, in their entirety. This letter contains the basic terms of your employment with the Company. If you agree to the terms and conditions set forth in this offer letter, please sign at the end of this letter in the space indicated. This Agreement shall be effective contingent upon, and from and after, the consummation of the Company’s initial public offering (the “IPO”) of its common stock, par value $0.001 per share (“Common Stock”).
Proteon Therapeutics, Inc. Waltham, MA 02451 October 1, 2014Employment Agreement • October 7th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Reference is hereby made to that certain Employment Letter Agreement, dated as of July 25, 2006, between you and Proteon Therapeutics, Inc. (the “Company” or “Proteon”), as amended by that certain First Amendment dated as of April 29, 2009 (as amended, the “Original Employment Agreement”). This letter agreement (the “Agreement”) amends and restates the Original Employment Agreement in its entirety. This letter contains the basic terms of your employment with the Company. If you agree to the terms and conditions set forth in this offer letter, please sign at the end of this letter in the space indicated. This Agreement shall be effective contingent upon, and from and after, the consummation of the Company’s initial public offering (the “IPO”) of its common stock, par value $0.001 per share (“Common Stock”).
Proteon Therapeutics, Inc. Waltham, MA 02451 October 1, 2014Employment Agreement • October 7th, 2014 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
Reference is hereby made to that certain Employment Letter Agreement, dated as of April 14, 2006, between you and Proteon Therapeutics, Inc. (the “Company” or “Proteon”), as amended by that certain First Amendment thereto, dated as of April 29, 2009 (as amended, the “Original Employment Agreement”). This letter agreement (the “Agreement”) amends and restates the Original Employment Agreement in its entirety. This letter contains the basic terms of your employment with the Company. If you agree to the terms and conditions set forth in this offer letter, please sign at the end of this letter in the space indicated. This Agreement shall be effective contingent upon, and from and after, the consummation of the Company’s initial public offering (the “IPO”) of its common stock, par value $0.001 per share (“Common Stock”).
